Introduction The current treatment paradigm for intracranial arteriovenous malformations
(AVMs) focuses on reducing the risk of intracranial hemorrhage using various therapeutic …

OBJECT Resection is an appealing therapy for brain arteriovenous malformations (AVMs)
because of its high cure rate, low complication rate, and immediacy, and has become the …

Object The effectiveness and risk of stereotactic radiosurgery (SRS) in the management of
partially embolized intracranial arteriovenous malformations (AVMs) remain controversial …

Objectives To evaluate the safety and efficacy of a new liquid embolic agent in brain
arteriovenous malformation (bAVMs) embolisation. Methods A prospective, multicentre …

Background In the past decade, preoperative endovascular embolization of cerebral
arteriovenous malformations (AVMs) became an essential tool in the treatment of these …

For the first time, the collective data on the biological, chemical, and medical actions of
DMSO are presented and analyzed from the published scientific literature. This book …

Preliminary experience with Squid: A New Liquid embolizing Agent for AvM, Av Fistulas and
Tumors Page 1 O rig inal In vestigation Turk Neurosurg 2014, Vol: 24, No: 4, 565-570 565 …

Advancement in microcatheter design and emergence of new embolic agents offer better
results in endovascular treatment of brain arteriovenous malformations (AVMs). Precipitating …

Arteriovenous malformations have a significant cumulative risk for hemorrhage. Treatment
options include observation, microsurgical resection, stereotactic radiosurgery …

OBJECTIVE The primary goal of the treatment of cerebral arteriovenous malformations
(AVMs) is angiographic occlusion to eliminate future hemorrhage risk. Although multimodal …